Back to Cerity Partners LLC Cerity Partners LLC

CORTCORT

Showing 8 of 12 quarters

Position history for Cerity Partners LLCCerity Partners LLC's holdings in Corcept Therapeutics Incorporated.

Yes. Cerity Partners holds 797,119 shares of CORT (Corcept Therapeutics), worth $69.3M, as of its Q2 2026 13F filing. It increased the position by 65,430 shares (+8.9%) from Q1 2026. Cerity Partners has held CORT since Q3 2023, across 12 quarterly 13F filings. CORT is 0.1% of Cerity Partners' reported 13F portfolio.

Current Value

$69.3M

Current Shares

797,119

Total Value Change

+$41M

Total Shares Change

+185,335

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
797,119
+8.9%
$69.3M0.1%$86.95
32
2026-Q1
Decreased
731,689
-3.1%
$29.5M0.0%$40.31
0
2025-Q4
Decreased
755,295
-0.4%
$26.3M0.0%$34.80
0
2025-Q3
Increased
758,426
+1.6%
$63M0.1%$83.11
36
2025-Q2
Increased
746,593
+21.4%
$54.8M0.1%$73.40
35
2025-Q1
Increased
614,794
+1.1%
$70.2M0.1%$114.22
36
2024-Q4
Decreased
607,946
-0.6%
$30.6M0.1%$50.39
0
2024-Q3
Decreased
611,784
-9.4%
$28.3M0.1%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used